课题基金 / 基金详情

Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)

Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)
抗血栓治疗可改善社区获得性肺炎的临床并发症 (ATTACC-CAP)
批准号:
463407
负责人:
Zarychanski Ryan
金额:
$288.63万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2027-03-01

项目摘要

项目成果

Zarychanski Ryan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Community acquired pneumonia (CAP) is an acute infection of the lungs acquired outside of a hospital setting. CAP is one of the most common causes of mortality in the world and results in critical illness and death in a significant proportion of patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTI-THROMBOTIC THERAPY TO AMELIORATE COMPLICATIONS OF COVID-19 (ATTACC): A randomized, international, multi-centre, adaptive, controlled clinical trial
  • 批准号:
    429655
  • 项目类别:
    Operating Grants
  • 资助金额:
    $260.32万
  • 财政年份:
    2020
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
Integrating clinical data systems to improve the capacity, performance, and value of Manitoba's healthcare system
  • 批准号:
    405787
  • 项目类别:
    Operating Grants
  • 资助金额:
    $174.34万
  • 财政年份:
    2019
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
Tranexamic acid to reduce red blood cell transfusion in major non-cardiac surgery (TRACTION): A pragmatic, registry-based, pilot, randomized controlled trial
  • 批准号:
    398808
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2018
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
Integrating clinical data systems to improve the capacity, performance, and value of Manitoba's healthcare system
  • 批准号:
    378856
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2018
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
海外基金